Estrogen Treatment Enhances Nitric Oxide Bioavailability in Normotensive but not Hypertensive Rats

American Journal of Hypertension

Volumn 19, Issue 8, 2006, Pages 859-866

  Hamilton, Carlene A ^a   Groves, Samantha ^a   Carswell, Hilary V O ^b   Brosnan, M Julia ^a   Graham, Delyth ^a   Dominiczak, Anna F ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Animal models of human disease; endothelial function; estrogens; hypertension; nitric oxide

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CARBACHOL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTROGEN; LUCIGENIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHENYLEPHRINE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PLACEBO; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD PRESSURE; CAROTID ARTERY; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; HYPERTENSION; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; STROKE; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BLOOD PRESSURE; ENDOTHELIAL CELLS; ESTROGENS; FEMALE; HYPERTENSION; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHENYLEPHRINE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTORS, ESTROGEN; SUPEROXIDES;

EID: 33746303621     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2006.01.008     Document Type: Article

References (35)

1. Stampfer M.J., Golditz G.A., Willett W.C., Manson J.E., Rosner B., Speizer F.E., and Hennekens C.H. Postmenopausal estrogen therapy and cardiovascular disease. ten-year follow-up from the Nurses' Health Study. N Engl J Med 325 (1991) 756-762
2. Pinto S., Virdis A., Ghiadoni L., Bernini G., Lombardo M., Petraglia F., Genazzani A.R., Taddei S., and Salvetti A. Endogenous estrogen and acetylcholine-induced vasodilation in normotensive women. Hypertension 29 (1997) 268-273
3. Huang A., Sun D., Koller A., and Kaley G. 17β-estradiol restores endothelial nitric oxide release to shear stress in arterioles of male hypertensive rats. Circulation 101 (2000) 94-100
4. Mori T., Durand J., Chen Y., Thompson A., Bakir S., and Oparil S. Effects of short-term estrogen treatment on the neointimal response to balloon injury of rat carotid artery. Am J Cardiol 85 (2000) 1276-1279
5. Herrington D.M., Reboussin D.M., Brosnihan K.B., Sharp P.C., Shumaker S.A., Snyder T.E., Furberg C.D., Kowalchuk G.J., Stuckey T.D., Rogers W.J., Givens D.H., and Waters D. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med 343 (2000) 522-529
6. Hulley S., Grady D., Bush T., Furberg C., Herrington D., Riggs B., and Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmeopausal women. JAMA 280 (1998) 605-613
7. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the women's health initiative randomized controlled trial. JAMA 288 (2002) 321-333
8. Virdis A., Pinto S., Versari D., Salvetti G., Bernini G., Fruzzetti F., Genazzani A.R., Taddei S., and Salvetti A. Effect of oral contraceptives on endothelial function in the peripheral microcirculation of healthy women. J Hypertens 21 (2003) 2275-2280
9. Cerquetani E., Vitale C., Mercuro G., Fini M., Zoncu S., and Rosano G.M.C. Comparative vascular effects of hormone replacement therapy and raloxifene in women at increased cardiovascular risk. Gynecol Endocrinol 18 (2004) 291-298
10. Khalil R.A. Sex hormones as potential modulators of vascular function in hypertension. Hypertension 46 (2005) 249-254
11. Barbacanne M.A., Rami J., Michel J.B., Souchard J.P., Philippe M., Besombes J.P., Bayard F., and Arnal J.F. Estradiol increases rat aorta endothelium-derived relaxing factory (EDRF) activity without changes in endothelial NO synthase gene expression. possible role of decreased endothelium-derived superoxide anion production. Cardiovasc Res 41 (1999) 672-681
12. Wagner A.H., Schroeter M.R., and Hecker M. 17β-estradiol inhibition of NADPH oxidase expression in human endothelial cells. FASEB J 15 (2001) 2121-2130
13. Mendelsohn M.E. Nongenomic, estrogen receptor-mediated activation of endothelial nitric oxide synthase. How does it work? What does it mean?. Circ Res 87 (2000) 677-682
14. Simoncini T., Hafezi-Moghadam A., Brazil D.P., Ley K., Chin W.W., and Liao J.K. Interaction of estrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407 (2002) 538-541
15. Hu F.B., Stampfer M.J., Manson J.E., Grodstein F., Colditz G.A., Speizer F.E., and Willett W.C. Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women. N Engl J Med 343 (2000) 530-537
16. The Scottish Health Survey 1998. Prevalence of cardiovascular disease and its risk factors 1 (1998) 21
17. Brosnan M.J., Hamilton C.A., Graham D., Lygate C.A., Jardine E., and Dominiczak A.F. Irbesartan lowers superoxide levels and increases nitric oxide bioavailability in blood vessels from spontaneously hypertensive stroke-prone rats. J Hypertens 20 (2002) 281-286
18. Kerr S., Brosnan M.J., McIntyre M., Reid J.L., Dominiczak A.F., and Hamilton C.A. Superoxide anion production is increased in a model of genetic hypertension. the role of the endothelium. Hypertension 33 (1999) 1353-1358
19. Taddei S., Virdis A., Ghiadoni L., Magagna A., and Salvetti A. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation 97 (1998) 2222-2229
20. Davidson A.O., Schork N., Jaques B.C., Kelman A.W., Sutcliffe R.G., Reid J.L., and Dominiczak A.F. Blood pressure in genetically hypertensive rats. influence of the Y chromosome. Hypertension 26 (1995) 452-459
21. Fennell J.P., Brosnan M.J., Frater A.J., Hamilton C.A., Alexander M.Y., Nicklin S.A., Heistad D.D., Baker A.H., and Dominiczak A.F. Adenovirus-mediated overexpression o extracellular superoxide dismutase improves endothelial dysfunction in a rat model of hypertension. Gene Therapy 9 (2002) 110-117
22. Vaillant C., Chesnel F., Schausi D., Tiffoche C., and Thieuland M.-L. Expression of estrogen recptor subtypes in rat pituitary gland during pregnancy and lactation. Endocrinology 143 (2002) 4249-4258
23. Rubanyi G.M., Johns A., and Kauser K. Effect of estrogen on endothelial function and angiogenesis. Vascular Pharmacol 38 (2002) 89-98
24. Hamilton C.A., Brosnan M.J., Al-Benna S., Berg G., and Dominiczak A.F. NAD(P)H oxidase inhibition improves endothelial function in rat and human blood vessels. Hypertension 40 (2002) 755-762
25. Rubanyi G.M., Freay A.D., Kauser K., Sukovich D., Burton G., Lubahn D.B., Couse J.F., Curtis S.W., and Korach K.S. Vascular estrogen receptors and endothelium-derived nitric oxide production in the mouse aorta. Gender difference and effect of estrogen receptor gene disruption. J Clin Invest 99 (1997) 2429-2437
26. Kobayashi T., Taguchi K., Yasuhiro T., Matsumoto T., and Kamata K. Impairment of PI3-K/Akt pathway underlies attenuated endothelial function in aorta of type 2 diabetic mouse model. Hypertension 44 (2004) 956-962
27. Shaul Philip W. Regulation of endothelial nitric oxide synthase. location, location, location. Annu Rev Physiol 64 (2002) 749-774
28. Chen Z., Yuhanna I.S., Galcheva-Gargova Z., Karas R.G., Mendelsohn M.E., and Shaul P.W. Estrogen receptor α mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 103 (1999) 401-406
29. Haynes M.P., Sinha K., Russell K.S., Collinge M., Fulton D., Morales-Ruiz M., Sessa W.C., and Bender J.R. Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the P13-kinase-Akt pathway in human endothelial cells. Circ Res 87 (2000) 677-682
30. Iaccarino G., Ciccarelli M., Sorrriento D., Cipolletta E., Cerullo V., Iovino G.L., Paudice A., Elia A., Santulli G., Campanile A., Arcucci O., Pastore L., Salvatore F., Condorelli G., and Trimarco B. AKT participates in endothelial dysfunction in hypertension. Circulation 109 (2004) 2587-2593
31. Oudit GY, Sun H, Kerfant BG, Crackower MA, Penninger JM, Backx PH: The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease. J Mol Biol 2004;37:449-471.
32. Northcott C.A., Hayflick J., and Watts S.W. Upregulated function of phosphatidylinositol-3-kinase in genetically hypertensive rats. a moderator of arterial hypercontractility. Clin Exp Pharmacol Physiol 32 (2005) 851-858
33. Stier Jr. C.T., Chander P.N., Rosenfeld L., and Powers C.A. Estrogen promotes microvascular pathology in female stroke-prone spontaneously hypertensive rats. Am J Physiol Endocrinol Metab 285 (2003) E232-E239
34. Gross M.L., Adamczak M., Rabe T., Harbi N.A., Krtil J., Koch A., Hamar P., Amann K., and Ritz E. Beneficial effects of estrogens on indices of renal damage in uninephrectomized SHRSP rats. J Am Soc Nephrol 15 (2004) 348-358
35. Simoncini T., Genazzani A.R., and Liao J.K. Nongenomic mechanisms of endothelial nitric oxide synthase activation by the selective estrogen receptor modulator raloxifene. Circulation 105 (2002) 1368